Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Allemagne (2)
Care Delivery/ Care pathway
Musculoskeletal/Multiple Sclerosis (MS) (1)
Start Up (3)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Representativeness of stakeholders
Clinical study phase II